MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Investigating the clinical predictors of depression in Huntington’s disease: An Enroll-HD Database Study

    E. Furr Stimming, G. Colpo, N. Rocha, A. Teixeira (Houston, TX, USA)

    Objective: This study was designed to investigate clinical predictors of depression in subjects with HD. Background: Huntington’s disease (HD) is characterized by motor, cognitive and…
  • 2018 International Congress

    Cerebrospinal fluid flow dynamics in Huntington’s disease evaluated by phase contrast MRI

    F. Rodrigues, L. Byrne, E. De Vita, E. Johnson, N. Hobbs, J. Thornton, R. Scahill, E. Wild (London, United Kingdom)

    Objective: To elucidate the dynamics of CSF flow through the neuraxis in Huntington’s disease (HD) using phase contrast magnetic resonance imaging (PCMRI). Background: HD is…
  • 2018 International Congress

    Effectiveness of peloid therapy in management of Parkinson’s disease (PD): A single center experience

    C.S. Khoo, E. Tokareva, O. Rybalko, I. Sukhareva (Cheras, Malaysia)

    Objective: To evaluate the effectiveness of peloid therapy in patients with Parkinson’s disease (PD). Background: PD is a progressive neurodegenerative movement disorder, which cannot be…
  • 2018 International Congress

    Auditory rhythmic cueing changes motor control during walking in Parkinson’s disease

    A. Islam, C. Chen, l. Alcock, K. Nazarpour, L. Rochester, A. Pantall (Newcastle-upon-Tyne, United Kingdom)

    Objective: (1) Evaluate changes in gait motor activity patterns induced by auditory rhythmic cueing in people with PD. (2) Investigate change in gait parameters. Background:…
  • 2018 International Congress

    Using APPs in a Movement Disorders clinic can quickly and efficiently increase the number of new patients seen without compromising patient satisfaction

    J. Atem, L. Lanford (Dallas, TX, USA)

    Objective: Using APPs in a Movement Disorders clinic can quickly and efficiently increase the number of new patients seen without compromising patient satisfaction The purpose…
  • 2018 International Congress

    Which is the best manual test to predict the daily living activities’ independence in people with Parkinson’s disease?

    C. Dionizio Dias, E. Okamoto, C. Miranda, M. d'Alencar, M.E. Piemonte (São Paulo, Brazil)

    Objective: The purpose of this study was to verify the power of Nine Hole Peg Test (9HPT) and manual strength (MS) to predict the decrease…
  • 2018 International Congress

    Burden of progressive supranuclear palsy: A systematic literature review

    S. Chen, I. Jakab, T. Zelei, L. Szilberhorn, R. Bendes, B. Elezbawy, Z. Kaló, M. Mann, M. Potashman, J. Pitter (Cambridge, MA, USA)

    Objective: The objective of this research was to identify available data on burden of progressive supranuclear palsy (PSP), a 4-repeat tauopathy. Research questions focused on…
  • 2018 International Congress

    Quantitative Midbrain Measurement in Diagnosing Variants of Progressive Supranuclear Palsy

    H. Wang, YW. Zhang, J. Yuan, D. Xu, H. You, ML. Li, F. Feng (Beijing, China)

    Objective: To evaluate the effectiveness of quantitative midbrain measurements in differentiating vPSP from multiple system atrophy (MSA) and Parkinson’s disease (PD). Background: Newly published criteria…
  • 2018 International Congress

    Pupillary autonomic dysfunction and oculomotor characteristics of multiple system atrophy

    K.W. Park, EJ. Lee, N.R. Choi, M.S. Kim, S.J. Chung (Seoul, Republic of Korea)

    Objective: To investigate the pupillary autonomic function and oculomotor characteristics of patients with multiple system atrophy (MSA). Background: MSA is a debilitating neurodegenerative disorder with…
  • 2018 International Congress

    Effects of mannitol treatment in a mice model of multiple system atrophy (MSA)

    N. Lev, Y. Barhum (Kfar Saba, Israel)

    Objective: The aim of this study was to examine the effect of mannitol treatment in a mice model of MSA. Background: Alpha-synuclein aggregation represents the…
  • « Previous Page
  • 1
  • …
  • 107
  • 108
  • 109
  • 110
  • 111
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley